911426-09-0 Usage
Description
Benzenemethanamine, 3,5-dibromo-α-methyl-, (αS)is a chiral chemical compound characterized by a complex molecular structure. The presence of 3,5-dibromo and α-methyl groups endows it with high reactivity, making it a potentially versatile building block for various chemical reactions and processes. Its specific three-dimensional arrangement of atoms and the potential for diverse applications in pharmaceuticals, materials science, and other fields of chemistry and industry highlight its significance in research and development.
Uses
Used in Pharmaceutical Industry:
Benzenemethanamine, 3,5-dibromo-α-methyl-, (αS)is used as an intermediate in the synthesis of pharmaceutical compounds for its high reactivity and unique molecular structure, which can contribute to the development of new drugs with specific therapeutic properties.
Used in Materials Science:
In the field of materials science, Benzenemethanamine, 3,5-dibromo-α-methyl-, (αS)is utilized as a component in the creation of advanced materials, taking advantage of its reactive groups to form novel materials with desired properties for various applications.
Used in Chemical Research:
Benzenemethanamine, 3,5-dibromo-α-methyl-, (αS)serves as a valuable subject for chemical research, allowing scientists to explore its unique reactivity and potential uses in developing new chemical processes and understanding its behavior in different reaction conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 911426-09-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,1,4,2 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 911426-09:
(8*9)+(7*1)+(6*1)+(5*4)+(4*2)+(3*6)+(2*0)+(1*9)=140
140 % 10 = 0
So 911426-09-0 is a valid CAS Registry Number.
911426-09-0Relevant articles and documents
Indanyl-piperazine compounds
-
Page/Page column 24, (2010/11/24)
A compound selected from those of formula (I): wherein: R3 represents a hydrogen atom, and R1 and R2 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, ?or R1 represents a hydrogen atom, and R2 and R3 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, n represents 1 or 2, —X— represents a group selected from —(CH2)m—O-Ak-, —(CH2)m—NR4-Ak-, —(CO)—NR4-Ak- and —(CH2)m—NR4-(CO)—, ?m represents an integer between 1 and 6 inclusive, Ak represents an optionally substituted alkylene chain, and R4 represents a hydrogen atom or an alkyl group, Ar represents an aryl or heteroaryl group, its enantiomers, diasteroisomers, and addition salts thereof with a pharmaceutically acceptable acid. Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK1 antagonist.
